公司資料
PerkinElmer 股價、新聞與催化劑
- 股票代碼:
- RVTY
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- United States
股票表現
116.17 USD (-0.57%)
收盤價
最後更新: 2026年8月17日
11.2B USD
市值
股價為何變動
As of Aug 17, 2026, RVTY closed down 0.57% at $116.17. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Revvity is a life sciences tools and diagnostics company with exposure to discovery, reproductive health, applied markets, and clinical testing. The company evolved from PerkinElmer into a more focused platform around testing and life sciences infrastructure.
所在地與產業分類
Headquartered in the United States and listed on NYSE, Revvity has a global footprint in life sciences tools and diagnostics. It sits in research and diagnostic infrastructure, not therapeutics.
商業模式特徵
The company earns revenue from instruments, consumables, software, and diagnostic workflows. Investors focus on lab demand, prenatal and reproductive testing, and the health of research spending across its core markets.
生技產業定位
Revvity sits in the biotech tools layer and benefits from the broader life sciences spending cycle. It is less binary than a drug stock, but it remains important because research and diagnostics budgets drive demand.
未來催化劑
- Revvity’s catalysts are diagnostics demand, pharma-tools recovery, and any signs that the research-market backdrop is improving. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。